Seeing Is Believing
HCAT is currently covered by 14 analysts with an average price target of $12.42. This is a potential upside of $4.29 (52.77%) from yesterday's end of day stock price of $8.13.
Health Catalyst's activity chart (see below) currently has 129 price targets and 131 ratings on display. The stock rating distribution of HCAT is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 37.59% with an average time for these price targets to be met of 103.06 days.
Highest price target for HCAT is $14, Lowest price target is $9, average price target is $12.42.
Most recent stock forecast was given by DANIEL GROSSLIGHT from CITI on 13-Nov-2024. First documented stock forecast 19-Aug-2019.
Currently out of the existing stock ratings of HCAT, 15 are a HOLD (33.33%), 30 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10.5
$2.37 (29.15%)
$12
11 days ago
(13-Nov-2024)
3/9 (33.33%)
$1.69 (19.18%)
269
Hold
$9
$0.87 (10.70%)
$8
17 days ago
(07-Nov-2024)
7/13 (53.85%)
$0.43 (5.02%)
45
Buy
$10
$1.87 (23.00%)
$8
1 months 16 days ago
(08-Oct-2024)
4/8 (50%)
$2.17 (27.71%)
69
Buy
$11
$2.87 (35.30%)
$14
2 months 29 days ago
(26-Aug-2024)
2/11 (18.18%)
$3.84 (53.63%)
1
Buy
$11
$2.87 (35.30%)
$11
6 months 3 days ago
(21-May-2024)
4/11 (36.36%)
$4.23 (62.48%)
96
What is HCAT (Health Catalyst) average time for price targets to be met?
Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?
Which analyst has the most public recommendations on HCAT (Health Catalyst)?
Which analyst is the currently most bullish on HCAT (Health Catalyst)?
Which analyst is the currently most reserved on HCAT (Health Catalyst)?